| Business Summary | | Encision,
Inc.
is
the
developer
and
owner
of
the
AEM
technology
for
minimally
invasive
surgery.
Encision's
AEM
technology
provides
surgeons
with
the
desired
tissue
effects,
while
preventing
stray
electrosurgical
energy
that
can
cause
unintended
and
unseen
tissue
injury.
AEM
Laparoscopic
Instruments
incorporate
"active
electrode
monitoring"
technology
to
dynamically
and
continuously
monitor
the
flow
of
electrosurgical
current,
thereby
helping
to
prevent
patient
injury.
With
the
AEM
system,
surgeons
are
able
to
perform
electrosurgical
procedures
more
safely
and
efficaciously
than
is
possible
using
conventional
laparoscopic
instruments.
In
addition,
the
AEM
instruments
are
cost
competitive
with
the
standard
"non-shielded,
non-monitored"
laparoscopic
instruments. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | Encision
designs,
develops,
manufactures
and
markets
apatented
monopolar
electrosurgical
shielding
system
and
integrated
surgical
instruments
which
are
designed
to
provide
greater
safety
to
patients
who
undergo
laparoscopic
surgery.
For
the
three
months
ended
6/30/01,
revenues
rose
from
$511
thousand
to
$1
million.
Net
loss
fell
82%
to
$68
thousand.
Results
reflect
improved
sales
efforts,
product
offering
expansion,
higher
gross
margins
and
lower
R&D
and
personnel
costs. | More
from
Market Guide: Significant
Developments |
| Officers | | | FY2000 Pay | |
| James Bowman, 43 Pres,
CEO | $80K | David Newton, 53 VP,
Technology, Director | -- | Roger Odell, 49 VP-Bus.
Devel., Director | -- | Dollar amounts are as of 31-Mar-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|